Andrea DiFabio, CLO of Xenon Pharmaceuticals XENE, has filed 0 purchases and 2 sales on the open market. Over the past 12 months that comes to a net sale of $230.8K. The latest trade was on 03/13.

AD

AD

Andrea DiFabio

Chief Legal Officer

Company

Xenon Pharmaceuticals XENE

First filing

23/03/14

Trades

13 trades

Buys / sales

0 / 2

12-month net buying

−$230.8K

Last trade

03/13

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xenon PharmaceuticalsXENE	Open-market sale10b5-1 plan	03/13	03/13	1,342 sh	$55.23	$74,118.66	−15.5%
Xenon PharmaceuticalsXENE	Open-market sale10b5-1 plan	03/10	03/11	2,607 sh	$60.11	$156,706.77	−34.8%